March 04, 2024 08:00 AM Eastern Standard Time WATERTOWN, Mass.–(BUSINESS WIRE)–Nocion Therapeutics, a clinical-stage biopharmaceutical company, today announced that it has raised $62 million in Series B funding. Nocion is developing first and potentially best…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Nocion Therapeutics is raising $16,999,993.00 in new funding. Sources indicate as part of senior management President and Chief Operating Officer, Rick Batycky…
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Nocion Therapeutics is raising $24,999,994.00 in new funding. Sources indicate as part of senior management President and Chief Operating Officer, Rick Batycky…